Newborn screening programmes including genetic analyses: limits and risks of negative consequences?
Thauvin-Robinet
Christel
C
Munck
Anne
A
Roussey
Michel
M
Huet
Frédéric
F
Binquet
Christine
C
Girodon
Emmanuelle
E
D003550:Cystic Fibrosis / Q000175:diagnosis / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D005060:Europe; D005260:Female; D030342:Genetic Diseases, Inborn / Q000175:diagnosis*; D005820:Genetic Testing; D014943:Global Health; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D015997:Neonatal Screening / Q000379:methods*; D015397:Program Evaluation; D012307:Risk Factors
D019005:Cystic Fibrosis Transmembrane Conductance Regulator